Pantoprazole 20 mg + Aspirin IP 81 mg is a gastro-protective cardiovascular combination therapy designed for patients requiring long-term low-dose aspirin therapy. This dual formulation combines Pantoprazole, a proton pump inhibitor (PPI), with low-dose Aspirin (81 mg) in a gastro-resistant form to reduce gastric irritation and ulcer risk associated with chronic aspirin use. Pantoprazole works by suppressing gastric acid secretion, thereby protecting the stomach lining, while Aspirin acts as an antiplatelet agent that helps prevent blood clot formation. This combination is particularly beneficial in patients at risk of cardiovascular events who also have a history of gastric discomfort, gastritis, or peptic ulcer disease. The gastro-resistant technology ensures aspirin is released in the intestine rather than the stomach, enhancing tolerability and minimizing gastrointestinal side effects.
